-
-
-
-
-
-
-
Denali Therapeutics Announces Pricing of $275 Million Public Offering of Common Stock
-
-
-
-
-
-
-
Denali Therapeutics Announces Closing of Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
-
-
-
-
-
55,525 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All